Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6. Wang Q, Guo Y, Zhang RM, Ho J, et al. Lancet Infect Dis 2023 Sep 11:S1473-3099(23)00555.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Q, Guo Y, Zhang RM, Ho J, et al. Antibody neutralisation of emerging SARS-CoV-2 subvariants: EG.5.1 and XBC.1.6. Lancet Infect Dis 2023 Sep 11:S1473-3099(23)00555.
PMID: 37708906